1. Home
  2. IBTA vs FTRE Comparison

IBTA vs FTRE Comparison

Compare IBTA & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ibotta Inc.

IBTA

Ibotta Inc.

HOLD

Current Price

$32.07

Market Cap

855.3M

Sector

N/A

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$13.30

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBTA
FTRE
Founded
2011
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
855.3M
829.3M
IPO Year
2024
2023

Fundamental Metrics

Financial Performance
Metric
IBTA
FTRE
Price
$32.07
$13.30
Analyst Decision
Hold
Buy
Analyst Count
7
9
Target Price
$28.50
$14.06
AVG Volume (30 Days)
144.3K
1.5M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$342,389,000.00
$2,723,400,000.00
Revenue This Year
$2.02
N/A
Revenue Next Year
$8.96
$3.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.00
52 Week Low
$19.10
$3.97
52 Week High
$52.11
$18.67

Technical Indicators

Market Signals
Indicator
IBTA
FTRE
Relative Strength Index (RSI) 45.29 55.18
Support Level $28.68 $8.85
Resistance Level $35.11 $18.26
Average True Range (ATR) 2.32 0.78
MACD -0.44 -0.23
Stochastic Oscillator 30.01 9.69

Price Performance

Historical Comparison
IBTA
FTRE

About IBTA Ibotta Inc.

Ibotta Inc operates a digital promotions platform, the Ibotta Performance Network (IPN), which connects consumer packaged goods (CPG) brands with consumers through a network of publishers. It sources digital offers from clients and distributes them via its technology platform, earning revenue when promotions result in consumer transactions. The platform supports offers across grocery and general merchandise categories, including toys, clothing, beauty, electronics, pet, and home products. The majority of its revenues is derived from the fees charged to clients when consumers redeem offers on the IPN by purchasing promoted products.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: